Indegene Limited — Updates, 06-02-2025: Press Release

Indegene has expanded its presence in Europe by launching a new entity in Spain, marking a significant step in its strategic growth within the continent. This new hub will enhance delivery capabilities for its Europe-based clients, focusing on personalized healthcare professional (HCP) and patient experiences. Indegene is already bolstering its employee base in Spain with expertise in medical affairs, data and analytics, and digital marketing, among other areas.

According to Manish Gupta, Chairman and CEO, Spain represents a vital market due to its increasing R&D investments and a rich talent pool in the life sciences sector. The company's existing European footprint includes operations in the UK, Germany, Ireland, and Switzerland, and prior acquisitions, such as Trilogy Writing & Consulting GmbH, underscore its commitment to strengthening its capabilities in medical writing and consulting services. Indegene's global presence spans six operational hubs with a workforce exceeding 5,000 employees, emphasizing its capability to adapt and meet the demands of leading biopharma companies. This expansion presents a positive outlook for Indegene as it seeks to leverage its resources to drive innovation in the life sciences space.